D 10 (Didanosine delayed release 250 mg)
Pill imprint D 10 has been identified as Didanosine delayed release 250 mg.
Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for D 10 (Didanosine delayed release 250 mg)
Didanosine delayed release
- Imprint:
-
D
10 - Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0312
- Inactive Ingredients:
- sodium starch glycolate type A potato
carboxymethylcellulose sodium
sodium lauryl sulfate
hypromellose 2910 (3 mPa.s)
magnesium silicate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
diethyl phthalate
silicon dioxide
gelatin
titanium dioxide
ferrosoferric oxide
shellac
More resources
Didanosine delayed release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
